260 related articles for article (PubMed ID: 4550416)
1. Immunity in shigellosis. II. Protection induced by oral live vaccine or primary infection.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):12-6. PubMed ID: 4550416
[No Abstract] [Full Text] [Related]
2. Immunity in shigellosis. I. Response of man to attenuated strains of Shigella.
DuPont HL; Hornick RB; Snyder MJ; Libonati JP; Formal SB; Gangarosa EJ
J Infect Dis; 1972 Jan; 125(1):5-11. PubMed ID: 4550417
[No Abstract] [Full Text] [Related]
3. Immunity against dysentery after enteral immunization with live vaccine.
Denchev V; Trifonova A; Jeleva M; Duncheva S; Bratanova V; Dimitrova Z; Kovachev P
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):71-4. PubMed ID: 4613140
[No Abstract] [Full Text] [Related]
4. Live oral Shigella vaccine: vaccination schedule and the effect of booster dose.
Mel DM; Arsic BL; Radovanovic ML; Litvinjenko SA
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):109-14. PubMed ID: 4613128
[No Abstract] [Full Text] [Related]
5. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)].
Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247
[No Abstract] [Full Text] [Related]
6. Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Kotloff KL; Losonsky GA; Nataro JP; Wasserman SS; Hale TL; Taylor DN; Newland JW; Sadoff JC; Formal SB; Levine MM
Vaccine; 1995 Apr; 13(5):495-502. PubMed ID: 7639017
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic value of live, inactivated and cell-free dysentery vaccines.
Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127
[No Abstract] [Full Text] [Related]
8. An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
Levine MM; Rice PA; Gangarosa EJ; Morris GK; Snyder MJ; Formal SB; Wells JG; Gemski P; Hammond J
Am J Epidemiol; 1974 Jan; 99(1):30-6. PubMed ID: 4590191
[No Abstract] [Full Text] [Related]
9. Studies on vaccination against bacillary dysentery. 6. Protection of children by oral immunization with streptomycin-dependent Shigella strains.
Mel D; Gangarosa EJ; Radovanovic ML; Arsic BL; Litvinjenko S
Bull World Health Organ; 1971; 45(4):457-64. PubMed ID: 4948417
[TBL] [Abstract][Full Text] [Related]
10. Live attenuated Shigella flexneri mutants as vaccine candidates against shigellosis and vectors for antigen delivery.
Phalipon A; Sansonetti P
Biologicals; 1995 Jun; 23(2):125-34. PubMed ID: 7546655
[TBL] [Abstract][Full Text] [Related]
11. Oral vaccination of monkeys with an invasive Escherichia coli K-12 hybrid expressing Shigella flexneri 2a somatic antigen.
Formal SB; Hale TL; Kapfer C; Cogan JP; Snoy PJ; Chung R; Wingfield ME; Elisberg BL; Baron LS
Infect Immun; 1984 Nov; 46(2):465-9. PubMed ID: 6389344
[TBL] [Abstract][Full Text] [Related]
12. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri].
Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK
Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775
[No Abstract] [Full Text] [Related]
13. Oral immunization against dysentery.
Kétyi I; Rauss K; Vertényi A
Acta Microbiol Acad Sci Hung; 1974; 21(1-2):81-5. PubMed ID: 4613142
[No Abstract] [Full Text] [Related]
14. Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
Levine MM; Dupont HL; Gangarosa EJ; Hornick RB; Snyder MJ; Libonati JP; Glaser K; Formal SB
Am J Epidemiol; 1972 Jul; 96(1):40-9. PubMed ID: 4557072
[No Abstract] [Full Text] [Related]
15. Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
Levine MM; Gangarosa EJ; Werner M; Morris GK
J Pediatr; 1974 Jun; 84(6):803-6. PubMed ID: 4596999
[No Abstract] [Full Text] [Related]
16. Oral shigella vaccines.
Hale TL; Formal SB
Curr Top Microbiol Immunol; 1989; 146():205-11. PubMed ID: 2659269
[No Abstract] [Full Text] [Related]
17. Protection of adult rabbits and monkeys from lethal shigellosis by oral immunization with a thymine-requiring and temperature-sensitive mutant of Shigella flexneri Y.
Ahmed ZU; Sarker MR; Sack DA
Vaccine; 1990 Apr; 8(2):153-8. PubMed ID: 2186582
[TBL] [Abstract][Full Text] [Related]
18. Oral immunization of monkeys with polyvalent dysentery vaccine.
Dhikidze EK; Kavtaradze KN; Krilova RI; Rauss K; Kétyi I; Vertényi A
Acta Microbiol Acad Sci Hung; 1977; 24(1):7-12. PubMed ID: 412396
[TBL] [Abstract][Full Text] [Related]
19. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes.
Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M
Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927
[No Abstract] [Full Text] [Related]
20. Construction and evaluation of a double mutant of Shigella flexneri as a candidate for oral vaccination against shigellosis.
Sansonetti PJ; Arondel J
Vaccine; 1989 Oct; 7(5):443-50. PubMed ID: 2683460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
